WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 10'9701 Infant (under 12 months) mortality rate: 152
GDP / capita (US$): 20'5831 Child (under 5 years) mortality rate: 172

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 3'929  3'868  3'806  3'744  3'682  3'029  2'471  1'979 
Births 75  75  75  75  74  70  65  61 
Surviving infants 74  74  74  74  73  69  63  59 
Pop. less than 5 years 368  368  367  366  363  342  310  288 
Pop. less than 15 years 1'067  1'063  1'059  1'054  1'049  968  887  809 
Female 15-49 years 1'023  1'010  995  981  966  798  627  465 

Number of reported cases

(Click for retrospective incidence data for Panama)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  1'891  2'096 
Mumps
ChartChart
  132  108  165  134  111  303 
Pertussis
ChartChart
  19  42  47  36  66  19  641 
Polio*
ChartChart
 
Rubella
ChartChart
  580 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  19 
Tetanus (total)**
ChartChart
  10  10  31 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Panama)
Vaccine year result method % card seen                                                
BCG          99*  99  94  99*  99*  99*  97  99* 
DTP1          96  96  93  99  99*  99* 
DTP3          73  80  80  85  87  98  86  70 
DTP4          91  80 
IPV1          80  40 
HepB_BD          85  84  79  87  93 
HepB3          73  80  80  85  87 
Hib3          73  80  80  85  87 
JapEnc         
MCV1          99*  90  92  98  97  97  73  71 
MCV2          92  90  68  72  81  88 
PCV1          98  98  92  99*  89 
PCV3          82  47  63 
Pol3          72  80  80  87  91  99  86  70 
Rota1          98  96  93  99*  99* 
RotaC          87  87  87  92  95 
Rubella1          99*  90  92  98  97 
TT2plus          66  87  99*  99*  99*  32  16 
PAB         
VAD1          47  30  44  30  82 
YFV          60  69  52  99*  78 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Panama)
BCG
ChartChart
  99  99  95  98  99  99  97  99 
DTP1
ChartChart
  96  96  93  99  98  99  95  72 
DTP3
ChartChart
  73  80  80  85  87  98  86  47 
HepB3
ChartChart
  73  80  80  85  87 
HepB_BD
ChartChart
  85  84  79  87  93 
Hib3
ChartChart
  73  80  80  85  87 
MCV1
ChartChart
  90  90  92  98  97  97  73  71 
MCV2
ChartChart
  92  90  68  72  81  88 
PCV3
ChartChart
  82  75  68  62  55 
Pol3
ChartChart
  72  80  81  87  91  99  86  70 
RCV1
ChartChart
  90  90  92  98  97  97 
RotaC
ChartChart
  87  87  87  92  95 
YFV
ChartChart
 

Number of districts in the country 79  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 16
From 80 to 89% 15
From 50 to 79% 59
Less than 50% 9
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT Yes allgery to pertussis
DTaPHibHepIPV 2, 4, 6 months; Yes
DTwP 4 years; Yes
DTwPHib 18 months; Yes
HPV 10 years; +6 months; Yes
HepA 12, 18 months; Yes
HepB_Adult Yes risk groups
HepB_Pediatric birth; Yes
IPV 18 months; 4 years; Yes immunosuppressed
Influenza_Adult > 60 years; Yes and adults with chronic diseases, pregnant women, health care workers and other risk groups
Influenza_Pediatric 6-23, 24-59 months; Yes and children with chronic diseases
MMR 12, 18 months; Yes
MR 18 years; Yes CBAW, Postpartum and general population not vaccinated with MMR before.
MenACWY Yes outbreak resopnse
OPV 18 months; 4 years; Yes
Pneumo_conj 2, 4, 12 months; Yes and risk groups
Pneumo_ps > 60 years; Yes in risk groups
Rabies Yes Post exposure
Rotavirus 2, 4 months; Yes
Td Yes general population and risk groups
Tdap 10 years; Yes pregant women and risk groups
Varicella 15 months; Yes outbreaks
VitaminA 1 year; 2 years (x2); Yes and postpartum
YF 1 year; No high risk areas

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  No  No  No  No 
What years does the MYP cover? number 2'019    2'015    2'010     
Nº of districts with microplans that include activities to raise immunization coverage number 72  79  14  17  76  77  76 

System performance

Total Nº districts in country number 79  79  77  77  76  77  76 
Nº districts with DTP3 coverage >=80% number 49  54  67  58  76  57  61 
% of districts with DTP3 coverage >=80% From 0 to 100% 62  68  87  75  100  74  80 
Nº districts with measles (MCV1) coverage >=95% number 31  34  39  56  63  29  75 
% of districts with MCV1 coverage >=95% From 0 to 100% 39  43  51  73  83  38  99 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  Yes  No  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 87  87  100  99  99  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.